查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1445971

医用包装薄膜：市场占有率分析、产业趋势与统计、成长预测（2024-2029）

Medical Packaging Films - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年医用包装薄膜市场规模预计为78.9亿美元，预计到2029年将达到102.2亿美元，在预测期内（2024-2029年）增长5.31%，复合年增长率为

医用包装膜-市场

市场规模反映了包装薄膜产品在医疗包装行业中跨应用的价值，并经过实质计算。包装薄膜由聚乙烯、聚丙烯、双向拉伸聚对聚对苯二甲酸乙二酯、聚亚苯醚、聚氯乙烯、EVOH、聚苯乙烯（PS）、尼龙等塑胶材料製成，并根据市场研究范围考虑了各种金属。

主要亮点

  • 世界各国政府正在对医疗和药品产品及解决方案进行大量投资，以控制损害并防止 COVID-19 大流行的潜在復发。例如，根据健康指标与评估研究所（IHME）2021年9月发布的数据，2019年全球人均医疗支出为1,129美元，预计2050年将增加至1,515美元。创新包装和先发製人的措施预计将成为医疗产业的常态，从而推动对医疗包装薄膜的需求。
  • 研究的市场是包装产业中快速成长的部分，在供应链安全问题、不断变化的监管要求和供需失衡等挑战中，许多因素加速了成长。在预测期内，由于各个市场参与者采取多项措施来限制塑胶材料的使用，生质塑胶薄膜的份额预计将增加。然而，由于所研究市场的需求性质，与塑胶薄膜的其他最终用户产业相比，这些努力对以永续包装薄膜取代塑胶薄膜的影响较小，这可能会维持市场成长。
  • 由于治疗癌症等慢性疾病的药物的增加以及对治疗药物的小袋、袋子和小袋的需求不断增加，预计该市场将显着增长。此外，人口老化和糖尿病发病率预计将为市场扩张提供新的机会。
  • 市场成长的主要挑战包括原材料价格波动、持续的永续性倡议（例如用生物分解性材料取代塑料包装产品）以及在塑料包装中增加使用消费后回收（PCR）塑料，例如强制使用。通常，原材料成本占该行业销售额的 55-60%。因此，盈利对原物料价格波动更加敏感。软包装薄膜的主要投入成本是粗衍生品，本质上是不稳定的。
  • 在 COVID-19 大流行期间，包装薄膜製造商面临着大量持续近一到两年的长期问题。封锁的影响包括供应链中断、劳动力短缺、难以获得製造过程中使用的原材料、导致最终产品产量激增并超出预算的价格波动以及运输问题。

医用包装薄膜市场趋势

对生质塑胶材料和可回收包装材料的需求不断增长推动医疗包装薄膜市场

  • 生质塑胶已在市场上使用，并正在研究以减少对环境的影响。由于塑胶在工业上的广泛使用，废弃物量急剧增加。因此，在医疗应用中使用生物分解性塑胶有助于环境保护。
  • 医用袋因其保护医疗产品、便于运输、品牌宣传等主要优点而广泛应用于医疗应用，特别是在需要大量、低成本包装时。这些袋子通常用于存放急救套件、药品和医疗设备。小袋可用于存放工具和化学品。
  • 此外，包装薄膜製造商正致力于使用可回收材料创新医疗包装解决方案，以提高其产品的永续性。例如，2021 年 11 月，永续包装解决方案提供商 Coveris 推出了基于 Flexopeel T 和 Formpeel T 品牌单膜的用于医疗包装的可回收单 PE 薄膜。该公司将杜邦的无涂层 Tyvek 1073B 与 Coveris 的 PE 树脂基单体结构薄膜相结合。
  • 随着包装产品製造商准备生质塑胶作为聚合物塑胶的替代品，包装行业对生质塑胶材料不断增长的需求正在推动市场研究。出于永续性考虑，生质塑胶的使用预计将减少禁令的影响，并减少医疗包装中聚合物塑胶包装的使用。根据欧洲生物塑胶公司统计，2021年全球软包装用生质塑胶产能为66.5万吨。
  • 研究市场中的主要企业正在推出新产品，以应对不断变化的消费者偏好并保持与市场需求的相关性。例如，加拿大包装和药物分配器公司 Jones Healthcare Group 于 2021 年 12 月透过为药局提供永续包装产品扩大了 Qube 和 FlexRx 药物依从性产品线。该公司推出了由生物材料製成的 Qube Pro、FlexRx One 和 FlexRx Reseal泡壳包装。 PET 是一种经医学核准的生质塑胶。

亚太地区预计将成为成长最快的市场

  • 亚太地区的成长率是受访市场中最高的，这主要是由于中国、印度、印尼和马来西亚等新兴经济体的中产阶级人口不断增长、可支配收入以及对医疗保健和药品的需求预期。该地区药品生产的快速成长极大地推动了该地区阻隔膜市场的成长。
  • 亚洲肾臟病率不断上升，需要开发新的治疗方法，包括改善治疗的先进设备。由于糖尿病和高血压的增加，亚洲肾臟病的盛行率正在增加。此外，人们越来越重视延长医疗设备和产品的保质期以及消除细菌和病毒污染的可能性，这增加了医疗保健产业对包装薄膜的需求。
  • 医用包装薄膜解决方案可为包装产品带来降低成本、永续性和安全性等优势，这就是为什么我们看到中国和印度等人口众多的新兴国家的医用包装薄膜显着增长。我是。此外，由于强大的工业基础、对永续包装解决方案不断增长的需求以及主要製造商在该地区的存在，预计亚太地区在金额和数量方面将领先所研究的市场。
  • 对植入式设备的需求不断增长以及医疗保健市场的快速增长也推动了对医用包装薄膜的需求。由于中国和印度等开发中国家对植入式设备的需求不断增长以及公众意识的不断提高，该市场不断扩大。
  • 随着医疗保健产业的扩张，中国医疗设备市场正以惊人的速度成长。这个特殊产业是中国成长最快的产业之一。由于动态监管，该行业正以两位数的成长率成长，其中近 70% 由医院采购贡献。传统上，中国医疗设备市场以其大量的低端耗材、机械治疗设备和辅助设备而闻名。所需的高端耗材传统上国内不生产，采购严重依赖进口。
  • 目前，医疗器械正在转向国产高价值、高风险的医疗设备，预计将推动中国医疗包装薄膜市场的发展。此外，人口老化是中国高端设备需求增加的驱动力之一。根据世界卫生组织(WHO)预测，到2040年，中国60岁以上人口的比例预计将达到28%。预计不断增长的人口将变得越来越富有，并且能够比以前在医疗保健服务上花费更多。

医用包装薄膜产业概况

医用包装薄膜市场本质上是分散的，Honeywell、3M、Amcor等主要企业正在采取各种策略，如新产品发布、合资、合作、收购等来利用这个市场，我们已经扩大了我们的基础的操作。

  • 2022 年 4 月 - Amcor 作为开发和製造负责任包装解决方案的全球领导者之一，宣布在其药品包装产品组合中添加永续高屏蔽层压板。新的低碳、可回收包装选项在两个方面提供支援：支援製药公司的可回收目标，同时满足产业所需的高阻隔阻隔性和性能要求。
  • 2022 年 1 月——内容回收产品和高阻隔保护包装领域的领先公司 Kloeckner Pentaplast 进行了大量投资，以进一步改进其永续产品，并扩大其在北美地区的废旧内容回收（PCR）宣布计划扩大PET产能。在消费者健康和药品食品包装市场提供创新。本公司具备生产能力，其产量20%以上为PCR材料。此次扩建将增加一条挤出生产线和两台热成型机，总合提供 15,000 吨新的 rPET 或 PET 产能。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 产业吸引力－波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代产品的威胁
    • 竞争公司之间的敌意强度
  • 产业价值链分析
  • 评估 COVID-19 对市场的影响

第五章市场动态

  • 市场驱动因素
    • 对生质塑胶和可回收包装材料的需求不断增加
    • 医疗设施支出增加主要是因为慢性病的增加
  • 市场限制因素
    • 原物料价格波动

第六章市场区隔

  • 材料类型
    • 塑胶薄膜
      • PE
      • PP
      • PVC
      • PC
    • 金属膜
  • 目的
    • 袋袋
    • 管子
    • 其他的
  • 地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第七章 竞争形势

  • 公司简介
    • Honeywell International Inc.
    • 3M Company
    • Wipak Oy
    • Amcor Plc
    • DuPont de Nemours, Inc.
    • Renolit Medical
    • PolyCine GmbH
    • Glenroy, Inc.
    • Toray Industries, Inc.
    • Klockner Pentaplast Group
    • Dunmore Corporation
    • Covestro AG

第八章投资分析

第九章市场机会与未来趋势

简介目录
Product Code: 68118

The Medical Packaging Films Market size is estimated at USD 7.89 billion in 2024, and is expected to reach USD 10.22 billion by 2029, growing at a CAGR of 5.31% during the forecast period (2024-2029).

Medical Packaging Films - Market

The market size reflects the value of packaging film products across medical packaging industry applications and is computed in the real term. Packaging films are made from plastic materials, such as polyethylene, polypropylene, biaxially oriented polyethylene terephthalate, polyphenylene ether, polyvinyl chloride, EVOH, polystyrene (PS), nylon, and various metals are considered as per the scope of the market study.

Key Highlights

  • Governments worldwide are heavily investing in medical and pharmaceutical products and solutions in damage control and the prevention of any potential resurgence of the COVID-19 pandemic. For instance, according to the Institute for Health Metrics and Evaluation (IHME), published in September 2021, the global per capita health expenditure was USD 1,129 in 2019, and it is projected to increase to USD 1,515 by 2050. Innovative packaging and preemptive measures are expected to become the norm in the medical industry, driving the demand for medical packaging films.
  • The market studied is a burgeoning segment of the packaging sector, with many drivers accelerating the growth amid the challenges in the form of supply chain security woes, changing regulatory demands, and supply and demand imbalances. During the forecast period, bioplastic films are expected to increase their share on account of several initiatives taken by various market entities to curb the use of plastic materials. However, owing to the severe nature of the market studied, these initiatives are likely to have less impact on replacing plastic films with sustainable packaging films compared to other end-user industries of plastic films, thereby sustaining the market growth.
  • The market is expected to experience significant growth, owing to the increase in therapeutics for chronic illnesses, such as cancer and the increasing demand for pouches, bags, and sachets for therapeutic medicines. Additionally, the aging population and the incidence of diabetes are projected to present new opportunities for market expansion.
  • Some of the major challenges for the market growth are the volatility of raw material prices, the ongoing drive for sustainability, which includes replacing plastic-based packaging products with biodegradable materials, and mandates of using post-consumer recycled (PCR) plastics in plastic packaging. Usually, raw material costs are attributed to 55-60% of sales in this industry. Therefore, profitability is vulnerable to volatility in raw material prices. The key input cost for flexible packaging film is crude derivatives, which have been inherently volatile.
  • During the COVID-19 pandemic, packaging film manufacturers were flooded with a pool of issues that lasted long for nearly one or two years. Some of the effects of lockdown included supply chain disruptions, labor shortages, lack of availability of raw materials used in the manufacturing process, fluctuating prices that caused the production of the final product to inflate and go beyond budget, transportation problems, etc.

Medical Packaging Films Market Trends

Increasing Demand for Bioplastic Material and Recyclable Packaging Material Drives the Medical Packaging Films Market

  • Bioplastics are being used in the market studied to reduce environmental impact. The amount of waste increased dramatically due to the extensive use of plastics in the industry. Thus, using biodegradable plastic in medical applications contributes to environmental protection.
  • Medical bags are widely used in medical applications, particularly when low-cost packaging in large quantities is required, owing to the primary benefits, such as medical product protection, ease of transportation, and brand promotion. These bags are frequently used to store first aid kits, medications, and medical equipment. Pouches can be used to store tools or liquid medications.
  • Moreover, packaging film manufacturers are focusing on innovating medical packaging solutions with recyclable materials to achieve greater sustainability in their product offerings. For instance, in November 2021, Coveris, a sustainable packaging solution provider, launched recyclable mono-PE film based on mono films branded Flexopeel T and Formpeel T for medical packaging. The company combined an uncoated Tyvek 1073B from DuPont and a mono-structure film from Coveris, based on PE resins.
  • The increasing demand for bioplastic material in the packaging segment has been driving the market study, as packaging product producers have alternatives for polymer-based plastic in the form of bioplastic. Using bioplastic reduced the impacts of bans and an anticipated reduction in polymer plastic-based packaging usage in medical packaging, owing to sustainability concerns. According to European Bioplastics, in 2021, the global production capacity of bioplastics for flexible packaging was 665,000 metric tons.
  • Key players in the market studied are launching new products to cater to changing consumer preferences and stay relevant to market demand. For instance, the Canadian packaging and medication dispenser company Jones Healthcare Group expanded the Qube and FlexRx medication adherence product lines for pharmacies with sustainable packaging products in December 2021. The company launched Qube Pro, FlexRx One, and FlexRx Reseal blister packs made of Bio-PET, a bioplastic that received medical approval.

Asia Pacific is Expected to be the Fastest Growing Market

  • The Asia Pacific is expected to expand with the highest growth rate in the market studied, majorly due to the increasing middle-class population, disposable incomes, and demand for medical and pharmaceutical products in developing economies such as China, India, Indonesia, and Malaysia. The booming pharmaceutical production in the region is significantly driving the growth of the barrier film market in the region.
  • The increasing prevalence of kidney disease in Asia necessitated the development of new therapies, including sophisticated devices to improve treatment. The prevalence of kidney disease in Asia is increasing due to increasing rates of diabetes and hypertension. Furthermore, the emphasis on extending the shelf life of medical devices and products and eliminating the possibility of bacterial or viral contamination increased the demand for packaging film in the medical and healthcare industries.
  • As medical packaging film solutions offer benefits, like cost savings, sustainability, and safety of packaged products, significant growth has been seen for medical packaging films from populated developing countries, such as China and India. Moreover, the Asia-Pacific region is anticipated to lead the market studied in terms of value and volume due to the solid industrial base, increased demand for sustainable packaging solutions, and the presence of key manufacturers in the region.
  • The demand for medical packaging films is also fueled by the increasing demand for implantable devices and the booming healthcare market. The market expanded due to the escalating demand for implantable devices and increasing public awareness in developing nations like China and India.
  • Along with the expanding healthcare sector, China's medical device market is increasing at an incredible pace. This specific sector is one of the fastest-increasing sectors in China. The sector is increasing at a double-digit growth rate, driven by dynamic regulations, nearly 70% of which was contributed to by hospital procurement. Traditionally China's medical devices market is well known for large volumes of low-end consumables, mechanotherapy devices, and aids. There has been large dependence on imports for procuring required high-end consumables as they were not traditionally manufactured in the country.
  • Currently, there has been a shift toward domestically made high-value and high-risk medical devices, which are expected to drive the Chinese medical packaging film market. Moreover, the aging population is one of the driving factors for the increase in demand for high-end Chinese devices. According to the World Health Organization (WHO), the population aged more than 60 years is expected to reach 28% in China by 2040. This increasing demographic, which is increasingly affluent, is expected to be able to spend more on healthcare services than before.

Medical Packaging Films Industry Overview

The Medical Packaging Films Market is fragmented in nature, and the major players such as Honeywell, 3M, Amcor, etc. have used various strategies such as new product launches, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

  • April 2022 - Amcor, one of the global leaders in developing and producing responsible packaging solutions, announced the addition of sustainable high shield laminates to its pharmaceutical packaging portfolio. The new low carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements needed for the industry while supporting pharmaceutical companies' recyclable objectives.
  • January 2022 - Klockner Pentaplast, a leading company in recycled content products and high-barrier protective packaging, announced its plans to expand its post-consumer recycled content (PCR) PET capacity in the North America region with a significant investment to further increase its sustainable innovation offering in consumer health and pharmaceutical food packaging markets. The company has the capacity, with more than 20% of its volumes made from PCR material. The expansion is set to add an extrusion line and two thermoformers, providing a total of 15,000 metric tons of new rPET or PET capacity.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat Of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Bioplastic and Recyclable Packaging Material
    • 5.1.2 Increased Spending on Healthcare Facilities, Primarily Owing to Increase in Chronic Diseases
  • 5.2 Market Restraints
    • 5.2.1 Fluctuation in the Prices of Raw Materials

6 MARKET SEGMENTATION

  • 6.1 Material Type
    • 6.1.1 Plastic Film
      • 6.1.1.1 PE
      • 6.1.1.2 PP
      • 6.1.1.3 PVC
      • 6.1.1.4 PC
    • 6.1.2 Metallic Film
  • 6.2 Application
    • 6.2.1 Bags & Pouches
    • 6.2.2 Tubes
    • 6.2.3 Other Applications
  • 6.3 Geography
    • 6.3.1 North America
    • 6.3.2 Europe
    • 6.3.3 Asia Pacific
    • 6.3.4 Latin America
    • 6.3.5 Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Honeywell International Inc.
    • 7.1.2 3M Company
    • 7.1.3 Wipak Oy
    • 7.1.4 Amcor Plc
    • 7.1.5 DuPont de Nemours, Inc.
    • 7.1.6 Renolit Medical
    • 7.1.7 PolyCine GmbH
    • 7.1.8 Glenroy, Inc.
    • 7.1.9 Toray Industries, Inc.
    • 7.1.10 Klockner Pentaplast Group
    • 7.1.11 Dunmore Corporation
    • 7.1.12 Covestro AG

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS